Nature Communications · 2017 · 180 citations · 72 references
Natural SciencesBiophysicsChemistryChemical KineticsDrug DesignStructural BiologyBinding KineticsChemical Kinetics ModelingLigand Binding KineticsMolecular DynamicsProtein Interaction KineticsAll-atom Molecular DynamicsAll-atom SimulationsComputational KineticsDrug-protein Interaction KineticsKinetic Models Of BindingKinetics Of Complex AssociationProtein-ligand Binding DynamicsProtein-ligand Binding Kinetics
Abstract Understanding and control of structures and rates involved in protein ligand binding are essential for drug design. Unfortunately, atomistic molecular dynamics (MD) simulations cannot directly sample the excessively long residence and rearrangement times of tightly binding complexes. Here we exploit the recently developed multi-ensemble Markov model framework to compute full protein-peptide kinetics of the oncoprotein fragment 25–109 Mdm2 and the nano-molar inhibitor peptide PMI. Using this system, we report, for the first time, direct estimates of kinetics beyond the seconds timescale using simulations of an all-atom MD model, with high accuracy and precision. These results only require explicit simulations on the sub-milliseconds timescale and are tested against existing mutagenesis data and our own experimental measurements of the dissociation and association rates. The full kinetic model reveals an overall downhill but rugged binding funnel with multiple pathways. The overall strong binding arises from a variety of conformations with different hydrophobic contact surfaces that interconvert on the milliseconds timescale.
72
Alessandro Laio, Michele Parrinello · Proceedings of the National Academy of Sciences · 2002 · 5.7K citations · Full text
Natural Sciences, Chemistry, Physics +17
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations
Medicine, Oncology, Pharmacology +15